PERTH, Australia, Dec. 11, 2017 /Weed Wire/ — The Board of Zelda Therapeutics Ltd (ASX: ZLD, Zelda or the Company) is pleased to announce it has entered into a research agreement with Children’s Hospital of Philadelphia (CHOP) to study the pharmacology of cannabinoids.
Tag Archives: Zelda Therapeutics
PERTH, Australia, Sept. 13, 2017 /Weed Wire/ — The Board of Zelda Therapeutics Ltd (ASX: ZLD, Zelda or the Company) is pleased to announce it is making significant progress with its research programme in Chile.
Further to the ASX announcement dated 29 August 2017 title ‘Priority Share Offer for CannPal Animal Therapeutics Ltd IPO Shares’, the Board of Zelda Therapeutics Ltd wishes to clarify the Priority Offer Record Date.
The Board of Zelda Therapeutics Ltd is pleased to announce that its shareholders are invited to participate as a priority applicant in the prospectus capital raising of CannPal Animal Therapeutics Limited (CannPal) lodged with the ASIC.
PERTH, Australia, July 31, 2017 /Weed Wire/ — The Board of Zelda Therapeutics Ltd (ASX: ZLD, Zelda or the Company) is pleased to announce it has expanded its research collaboration with Complutense University.
In this Cal Can Biz interview, watch Caroline Cahill, Managing Editor of http://www.MJINews.com and Marijuana Industry News magazine, interview Mara Gordon, founder of Aunt Zelda’s.
PERTH, Australia, April 28, 2017 /Weed Wire/ — The Board of Zelda Therapeutics Ltd (ASX: ZLD, Zelda or the Company) is pleased to provide an operational update to accompany its Appendix 4C, released today, for the 3-month period to 31 March 2017.
It certainly has been a great day for pot stocks on the ASX. This morning Federal Health Minister Greg Hunt announced that the government would allow medical marijuana companies to distribute cannabis oils and medications in Australia within the next couple of months.
Roto-Gro International, a Canadian cannabis-tech company has been admitted to the ASX, and has become the latest player to join the list of cannabis based companies on the ASX.
Creso Pharma shares jumped when the medical cannabis company debuted on the ASX. The shares are up by a quarter since listing on Thursday at 25 cents.